AIM: The aim of the study was to analyze the clinical characteristics of death cases with Coronavirus Disease 2019 (COVID-19). METHODS: We collected clinical characteristics of confirmed COVID-19 patients who died from January 01, 2022, to March 31, 2022, in Prof. Dr. R. D. Kandou General Hospital, Manado, Indonesia. The patient’s clinical features were obtained from the electronic medical records: Age, sex, history of COVID-19 vaccination, type of vaccine, s-gene target failure (SGTF) result, duration of hospitalization, comorbidities, and cause of death. RESULTS: Seventy-nine medical records of COVID-19 patients treated and died at Prof. Dr. R. D. Kandou General Hospital, Manado, Indonesia, from January 01, 2022, to March 31, 2022. The mean age of patients was 56-years-old, 57% were males, and 43% were females. The mean duration of hospitalization was 5 days. Most patients (73%) had not received any COVID-19 vaccine. SGTF results showed a probable Omicron variant in 53% of the subject, 13% of non-probable Omicron, and 13% of others who did not have the test. A third of the deceased patients had at least one type of comorbid condition. Diabetes mellitus was the most common comorbidity in 66% of our subjects. Most of the issues died due to respiratory failure (63%), and the rest died due to multiple organ failures, septic shock, and cerebrovascular accidents. CONCLUSION: One-third of COVID-19 patients who died at least had one type of comorbidity, commonly diabetes mellitus. Most of the subjects died due to respiratory failure. Most of the deceased patients had not received any COVID-19 vaccination.
Introduction: Deaths due to the novel coronavirus (COVID-19) infection in Indonesia continue to increase each day. Limiting patient contact with family and health workers directly in the inpatient room can raise suspicion and complaints from the patient's family being treated. The risk of medical disputes can also arise due to the limited fulfillment of obtaining information from the patient or family. This study aims to highlight the role of hospital-assisted Tele-education in conveying information to family members regarding the death of their loved ones.Methods: This study is a descriptive quantitative study by taking secondary data from medical records and quality committee data in hospitals to compare patient complaints that arise before and after hospital tele-education policy in COVID-19 cases at Prof.dr.R.D Kandou hospital. Results: Tele-education implementation appears to increase. From 14.43% in the first month of implementation to 80.46%, after the policy was set at the end of the 6th month. The number of complaints related to patients hospitalized due to COVID-19 before the use of virtual education in the patient's family was 18.26%, and in cases where patients died, family complaints before the use of virtual education had a mean of 39.1%. After implementing the policy, the complaint rate for patients being treated fell to an average of 5.06%, and in deceased cases, the complaint rate decreased to an average of 8.95%. Conclusion: The number of cases that using virtual education increased each month, and the peak was in December 2020; meanwhile the lowest percentage was in July 2020. The use of virtual media in delivering family information and education reduces the barriers that are formed due to hospitalization in isolation rooms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.